Cancer patients and survivors are more likely to report housing and utility insecurity than those who do not have a history of cancer.

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Participants in intervention group reported lower rates of moderate-to-very severe symptoms, including anxiety, depression, pain, fatigue, constipation.

In this analysis of colorectal cancer patients from 2 clinical trials, researchers aimed to assess the effect of physical activity on overall survival.

Tanning bed usage was associated with an increased risk of melanoma, at an odds ratio of 2.85, while further analysis revealed a dose–response relationship between the number of tanning bed exposures ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Longitudinal data reveal consistent initial responsiveness to targeted agents but limited durability once patients cycle through both BTKi and BCL2i classes.

A low prognostic nutritional index may indicate a reduced response to ICIs due to diminished hepatic function and systemic inflammation.

Guidelines expanded to include self-collection for HPV testing and revised guidance for exiting cervical cancer screening.

Researchers compared eurythmy therapy with slow-paced physical exercises to determine their effectiveness on fatigue in patients with metastatic breast cancer.

Italian investigators sought to determine if combining R-CHOP plus ibrutinib followed by ibrutinib maintenance improved PFS in treatment-naive patients aged 65 years and younger with high-risk ABC ...